Toxicities Associated with CAR T-Cell Therapy — An Interview with Dr Matthew Lunning
Hematologic Oncology Update
00:00
Use of lisocabtagene in older patients
Dr Lunning explains preferring lisocabtagene for older or frailer patients and outcomes showing return to prior quality of life.
Play episode from 20:10
Transcript
